Sort
64,565 grants matching “drug discovery”
Biophysical mechanisms of gating and modulation in voltage-gated ion channel superfamily
$985,536Baron Chanda · Washington University · R35 · FY2023 · NS
Biophysical mechanisms of gating and modulation in voltage-gated ion channel superfamily
$985,529Baron Chanda · Washington University · R35 · FY2021 · NS
Biophysical mechanisms of gating and modulation in voltage-gated ion channel superfamily
$985,529Baron Chanda · Washington University · R35 · FY2020 · NS
Biophysical mechanisms of gating and modulation in voltage-gated ion channel superfamily
$985,455Baron Chanda · Washington University · R35 · FY2025 · NS
STTR Phase II: Deep Learning Technology For The Microscopic Analysis Of Stained Cells Using Unbiased Methods
$985,354Peter R Mouton · Stereology Resource Center, Inc. · · FY2019 · TIP
A novel protein engineering tool for rapid manufacturing of designer nucleosomes
$984,916Michael-Christopher Keogh · Epicypher, Inc. · R44 · FY2019 · CA
Developmental Biology and Solid Tumor
$984,904Richard James Gilbertson · St. Jude Children'S Research Hospital · P30 · FY2016 · CA
PIXUL-FFPE: High throughput platform for chromatin and DNA sample preparation from formalin fixed paraffin embedded (FFPE) tissue samples.
$984,799Karol Bomsztyk · Matchstick Technologies, Inc. · R42 · FY2021 · HG
Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohort
$984,329Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2022 · NS
Proteasome inhibitor re-sensitizing molecules for treatment of refractory multiple myeloma
$984,129Frank W. Marcoux · Leukogene Therapeutics, Inc. · R42 · FY2018 · CA
Biofluid Core
$984,055Adam L Boxer · Mayo Clinic Rochester · U19 · FY2024 · AG
Mapping polymicrobial interactions that modulate antibiotic persistence
$984,000Wendy W.k. Mok · University Of Connecticut Sch Of Med/Dnt · DP2 · FY2024 · AI
DNA 3.0: Development of a novel, efficient and cost-effective enzymatic process for synthesis of DNA oligonucleotides
$983,775Helge Zieler · Primrose Bio, Inc. · R44 · FY2023 · HG
Adaptable and scalable electroporation for cellular therapy
$983,392Harold G Craighead · Cytequest, Inc. · R44 · FY2025 · GM
2/7 Psychiatric Genomics Consortium: Finding Actionable Variation
$983,108Mark J Daly · Massachusetts General Hospital · U01 · FY2020 · MH
Discovery and Preclinical Development of Drugs for Anthrax, Plague and Tularemia
$983,072Christie G. Brouillette · University Of Alabama At Birmingham · U01 · FY2009 · AI
Development of the AcoustoDrop platform: an acoustofluidic-based, automated, liquid-handling system for manipulating and dispensing droplets in a rewritable, biocompatible, and high-throughput manner
$982,940Lin Wang · Ascent Bio-Nano Technologies, Inc. · R44 · FY2025 · GM
Development of the AcoustoDrop platform: an acoustofluidic-based, automated, liquid-handling system for manipulating and dispensing droplets in a rewritable, biocompatible, and high-throughput manner
$982,940Lin Wang · Ascent Bio-Nano Technologies, Inc. · R44 · FY2024 · GM
Rapid sensitive low-cost test for resistant microbes causing hospital infections
$982,928Sadanand Gite · First Light Diagnostics , Inc. · R44 · FY2011 · AI
Rapid dissection of the biosynthesis of antiMRSA antibiotics produced in co-culture by extremophilic fungi through the development of Fungal Artificial Chromosomes
$982,704Chengcang Charles Wu · Intact Genomics, Inc. · R44 · FY2023 · AI
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases
$982,500Joel S. Bader · Johns Hopkins University · U01 · FY2020 · CA
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases
$982,500Joel S. Bader · Johns Hopkins University · U01 · FY2021 · CA
4-(Aminomethyl) benzamides as novel anti-Ebola agents
$982,388Lijun Rong · Chicago Biosolutions, Inc. · R42 · FY2021 · AI
ICEES+ Knowledge Provider: Leveraging Open Clinical and Environmental Data to Accelerate and Drive Innovation in Translational Research and Clinical Care.
$982,187Stanley Carlton Ahalt · Univ Of North Carolina Chapel Hill · OT2 · FY2021 · TR
Nipah & Hendra Virus Nonhuman Primate Model & Therapeutics Development
$982,178Thomas William Geisbert · University Of Texas Med Br Galveston · U01 · FY2010 · AI